Financial Updates for the Psychedelics Industry | Microdose

Psychedelics News

Finance

14 Sep 2022

MindMed Retains its NASDAQ Listing

MindMed has received a letter from The Nasdaq Stock Market LLC advising the Company that it has regained compliance with Nasdaq's minimum bid price listing requirement....

By Microdose NewsDesk

Finance, Industry

1 Sep 2022

Cathie Wood’s ARK Invest Releases Psychedelic Research Report

Cathie Wood and the ARK Invest team have released a full report on the psychedelic sector and investment landscape....

By Jason Najum

Finance

27 Aug 2022

MindMed Completes 1-for-15 Reverse Share Split

MindMed Completes 1-for-15 Reverse Share Split....

By Microdose NewsDesk

Breaking News, Finance

18 Aug 2022

Breaking News: MindMed Stock Jumps Over 60%

Investors woke up this morning to a serious shroom stock buzz....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Finance, Industry

9 Aug 2022

Cybin Announces Financial Results and $35M Equity Program

Cybin has started the week off with several newsworthy stories....

By Microdose NewsDesk

Finance

4 Aug 2022

COMPASS Pathways Announces Q2 Results and Highlights

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights...

By Microdose NewsDesk

Finance

3 Aug 2022

Horizons Psychedelic ETF Performs 1:4 Share Consolidation

Shareholders of the Horizons Psychedelic Stock Index ETF (PSYK) might have noticed a sudden and drastic price change this week....

By Microdose NewsDesk

Finance

2 Aug 2022

Cathie Wood’s ARK Fund Buys Over 3 Million ATAI Shares

In mid-July, we had the ARK fund at a total investment of 621,812 shares for the month....

By Microdose NewsDesk

Breaking News, Finance

2 Aug 2022

Morgan Stanley Releases Positive Report on Psychedelics

In June, we reported on KPMG, a "Big Four" accounting firm, putting out a KPMG Releases Positive Report on Psychedelics, and now we have another positive report on psychedelics from...

By Jason Najum

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result